Colitis

26 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Colitis
Treatment and conditionWhere it standsTrials
AC-101 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Atorvastatin calcium trihydrate for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Bezlotoxumab for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Duvakitug for colitis, ulcerativePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Emvistegrast for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fecal Microbial Transplantation for colitis, ulcerativePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Fecal microbiota for colitisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Golimumab for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Guselkumab for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Infliximab for colitisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
INT-210 Capsule for colitis, ulcerativePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
JNJ-78934804 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Mirikizumab for colitis, ulcerativePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Obefazimod for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PALI-2108 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phentermine-Topiramate for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo-to-match emvistegrast + Emvistegrast for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
single FMT for colitis, ulcerativePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
SPY001 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY001 + SPY002 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY001 + SPY003 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY002 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY002 + SPY003 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
SPY003 for colitis, ulcerativePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)2
Vedolizumab for colitisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Vedolizumab for colitis, ulcerativePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1